Azitra, Inc. balance sheet
At the end of fiscal 2025, Azitra, Inc. had total assets of $5.0m, total liabilities of $1.2m and shareholders' equity of $3.8m. It held $2.1m in cash against $0 of debt: net cash of $2.1m.
Balance sheet
| Fiscal year | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|
| Cash and equivalents | 3 | 2 | 5 | 2 |
| Receivables | 0 | — | 0 | 0 |
| Total current assets | 4 | 3 | 5 | 3 |
| Total assets | 7 | 5 | 7 | 5 |
| Accounts payable | 1 | 1 | 0 | 0 |
| Deferred revenue (current) | 0 | — | — | — |
| Total current liabilities | 2 | 2 | 1 | 1 |
| Long-term debt | 7 | — | — | — |
| Total debt | 7 | — | 0 | 0 |
| Total liabilities | 10 | 2 | 2 | 1 |
| Shareholders' equity | −36 | 3 | 6 | 4 |
| Non-controlling interests and other (assets − liabilities − equity) | 34 | — | — | — |
| Net debt (negative = net cash) | 3 | −2 | −5 | −2 |
| Shares outstanding | 1m | — | — | — |
| Quarter | 2023 Q4Dec 2023 | 2024 Q1Mar 2024 | 2024 Q2Jun 2024 | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Receivables | — | — | — | — | 0 | 0 | 0 | 1 |
| Total current assets | 2,536 | 3,526 | 1,336 | 7,635 | 5,228 | 1,800 | 2,230 | 3,019 |
| Total assets | 5,115 | 6,068 | 3,883 | 9,777 | 7,359 | 3,956 | 4,300 | 5,025 |
| Accounts payable | 897 | 583 | 997 | 588 | 490 | 636 | 718 | 399 |
| Total current liabilities | 1,603 | 1,258 | 1,739 | 1,368 | 1,376 | 1,452 | 1,806 | 1,068 |
| Total liabilities | 2,202 | 1,744 | 2,156 | 1,719 | 1,661 | 1,727 | 2,021 | 1,224 |
| Shareholders' equity | 2,913 | 4,324 | 1,726 | 8,058 | 5,698 | 2,229 | 2,279 | 3,801 |
| Shares outstanding | — | 29m | — | 8m | 1m | 18m | 6m | 11m |
Compare with peers
- Creative Medical Technology Holdings, Inc. balance sheet
- Lyell Immunopharma, Inc. balance sheet
- AIM Immunotech Inc. balance sheet
- Ibio, Inc. balance sheet
- Lisata Therapeutics, Inc. balance sheet
Head to head: AZTR vs CELZAZTR vs LYELAIM vs AZTR
More: Biotechnology stocks compared, Health Care sector, rankings of US companies